Integrated Care for the Diabetic Patient - Part 1
The live program has concluded.
If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.
Overview
It remains clear that although diabetes is a systemic disorder, the manifestations of diabetic complications will occur without optimal glycemic and blood pressure control. Optometrists can help continually reinforce that message by educating patients about the necessity for ongoing and yearly dilated eye exams, and discussing the potential treatments should vision loss become obvious.This continuing education activity is supported through an unrestricted educational grant from Regeneron Pharmaceuticals. Learning Objectives
After successfully completing this activity, optometrists will have improved their ability to:
- Determine who is a high-risk patient for the onset of diabetic eye disease
- Discuss the importance of conducting yearly dilated exams on diabetic patients
- Develop plans to initiate comanagement of the diabetic patient with both ophthalmologists and primary care physicians/endocrinologists
- Implement strategies to educate patients on the ocular manifestations of diabetes
Accreditation
This course is COPE approved for 2.0 hours of CE credit for optometrists.
Participation Method
This educational activity consists of a supplement and 20 study questions. To obtain credit, the participant should read the learning objectives contained at the beginning of this activity, read the material, answer all questions in the post test, and complete the activity evaluation form. This educational activity should take a maximum of 2.0 hours to complete.
This continuing education activity captures content from a CE-accredited webinar held on Tuesday, June 21, 2016.
The target audience for this CE Activity is optometrists.
Faculty and Disclosures
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.Mark Dunbar, OD, moderator
A. Paul Chous, OD
Steven G. Ferrucci, OD
Jay M. Haynie, OD
Leo Semes, OD
Mark Dunbar, OD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan; Carl Zeiss Meditec; and Regeneron Pharmaceuticals.
A. Paul Chous, OD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Bausch + Lomb; CooperVision; Freedom Meditech; Regeneron Pharmaceuticals; and ZeaVision, LLC. Grant/ Research Support: ZeaVision, LLC
Steven G. Ferrucci, OD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Alcon; CenterVue; Macula Risk; and Maculogix.
Jay M. Haynie, OD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: ArticDx; Carl Zeiss Meditec; Reichert; Notal Vision, Ltd.; and ThromboGenics NV.
Leo Semes, OD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/ Speaker’s Bureau: Alcon; Allergan; Optovue; and Regeneron Pharmaceuticals. Stock/Shareholder: HPO
Cheryl Cavanaugh, MS, director of operations, Evolve Medical Education LLC; Michelle Dalton, medical writer; and Melanie Lawler, PhD, reviewer, have no relevant commercial interests to disclose.
Disclaimer
DISCLOSURE ATTESTATION
Each of the contributing physicians listed above has attested to the following: (1) that the relationships/affiliations noted will not bias or otherwise influence his or her involvement in this activity; (2) that practice recommendations given relevant to the companies with whom he or she has relationships/affiliations will be supported by the best available evidence or, absent evidence, will be consistent with generally accepted medical practice; and (3) that all reasonable clinical alternatives will be discussed when making practice recommendations.
PRODUCT USAGE IN ACCORDANCE WITH LABELING
Please refer to the official product information for each product for discussion of approved indications, contraindications, and warnings.
GRANTOR STATEMENT
This COPE CE Activity is supported through an unrestricted educational grant from Regeneron Pharmaceuticals.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education LLC, The University of Houston, Regeneron Pharmaceuticals, or Advanced Ocular Care.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Christina Y. Weng, MD, MBA, FASRS
Mark T. Dunbar, OD, FAAO
David A. Eichenbaum, MD, FAAO
Jaclyn Garlich, OD, FAAO
Mohammad R. Rafieetary, OD, FAAO, FORS, ABO
John W. Kitchens, MD
Sara LeMay, OD
Sunir J. Garg, MD, FACS, FASRS
Charles C. Wykoff, MD, PhD, FACS
